Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 27.10.2025Sandoz Pharmaceuticals d.d. (SAN-SLO-1)6364CVildagliptin/Metformin Sandoz 50 mg/850 mg (tbl flm 60x50 mg/850 mg (blis.PA/Al/PVC/Al))1.10.2025Z
 27.10.2025Sandoz Pharmaceuticals d.d. (SAN-SLO-1)9171EEdoxaban Sandoz 30 mg (tbl flm 30x30 mg (blis.PVC/Al))27.10.2025R
 27.10.2025Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99946Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 10x500 mg (blis.PP/Al))1.10.2025R
 27.10.2025Sandoz GmbH (SAN-A)0756ESitagliptin Sandoz 100 mg (tbl flm 98x100 mg (blis.PVC/PE/PVDC/Al-neperfor.))1.10.2025Z
 27.10.2025Sandoz GmbH (SAN-A)0753ESitagliptin Sandoz 100 mg (tbl flm 28x100 mg (blis.PVC/PE/PVDC/Al-neperfor.))1.10.2025Z
 27.10.2025Sandoz GmbH (SAN-A)91268Xorimax 250 mg (tbl obd 10x250 mg (blis. Al/Al))15.10.2025O
 27.10.2025Sandoz GmbH (SAN-A)98823Alfuzosin Sandoz 10 mg tablety s predĺženým uvoľňovaním (tbl plg 90x10 mg (blis.PVC/PVDC/Al))22.10.2025Z
 27.10.2025Sandoz Pharmaceuticals d.d. (SAN-SLO-4)90197Aclasta 5 mg infúzny roztok (sol inf 1x100 ml/5 mg (fľ.plast.))15.10.2025O
 27.10.2025Biosimilar Collaborations Ireland Limited (BTT)4878DNepexto 50 mg injekčný roztok v naplnenom injekčnom pere (sol inj 4x1 ml/50 mg (striek.inj.napl.skl. v pere))27.10.2025R
 27.10.2025Biosimilar Collaborations Ireland Limited (BTT)9996CFulphila 6 mg injekčný roztok naplnený v injekčnej striekačke (sol inj 1x0,6 ml/6 mg (striek.inj.napl.skl. s chráničom ihly))27.10.2025R
 26.10.2025STADA Arzneimittel AG (STD)8309EPerindopril/Indapamid/Amlodipín STADA 10 mg/2,5 mg/10 mg (tbl flm 30x10 mg/2,5 mg/10 mg (blis.Al/Al))24.10.2025U
 26.10.2025STADA Arzneimittel AG (STD)8310EPerindopril/Indapamid/Amlodipín STADA 10 mg/2,5 mg/10 mg (tbl flm 90x10 mg/2,5 mg/10 mg (blis.Al/Al))24.10.2025U
 24.10.2025Biosimilar Collaborations Ireland Limited (BTT)7539CSemglee 100 jednotiek/ml injekčný roztok v naplnenom pere (sol inj 5x3 ml/300 jednotiek (náplň skl. v pere))24.10.2025R
 24.10.2025Zentiva, k.s. (ZNT-1)00502Mesocain 1 % (sol inj 10x10 ml (amp. skl.))24.10.2025O
 24.10.2025Glenmark Pharmaceuticals s.r.o. (GLM-CZ)9018CGlezisim 10 mg/40 mg tablety (tbl 98x10 mg/40 mg (blis.PVC/Al/OPA/Al))30.10.2025Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)